412 related articles for article (PubMed ID: 26299226)
21. Rationale and design of PRIMA II: A multicenter, randomized clinical trial to study the impact of in-hospital guidance for acute decompensated heart failure treatment by a predefined NT-PRoBNP target on the reduction of readmIssion and Mortality rAtes.
Stienen S; Salah K; Moons AH; Bakx AL; van Pol PE; Schroeder-Tanka JM; Voogel AJ; Keijer JT; Kortz RA; Dickhoff C; Meregalli PG; Tijssen JG; Pinto YM; Kok WE
Am Heart J; 2014 Jul; 168(1):30-6. PubMed ID: 24952857
[TBL] [Abstract][Full Text] [Related]
22. Assessment of dyspnea in acute decompensated heart failure: insights from ASCEND-HF (Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure) on the contributions of peak expiratory flow.
Ezekowitz JA; Hernandez AF; O'Connor CM; Starling RC; Proulx G; Weiss MH; Bakal JA; Califf RM; McMurray JJ; Armstrong PW
J Am Coll Cardiol; 2012 Apr; 59(16):1441-8. PubMed ID: 22497823
[TBL] [Abstract][Full Text] [Related]
23. Sudden cardiac death after acute heart failure hospital admission: insights from ASCEND-HF.
Pokorney SD; Al-Khatib SM; Sun JL; Schulte P; O'Connor CM; Teerlink JR; Armstrong PW; Ezekowitz JA; Starling RC; Voors AA; Velazquez EJ; Hernandez AF; Mentz RJ
Eur J Heart Fail; 2018 Mar; 20(3):525-532. PubMed ID: 29266564
[TBL] [Abstract][Full Text] [Related]
24. Global variation in quality of care among patients hospitalized with acute heart failure in an international trial: findings from the acute study clinical effectiveness of nesiritide in decompensated heart failure trial (ASCEND-HF).
Howlett JG; Ezekowitz JA; Podder M; Hernandez AF; Diaz R; Dickstein K; Dunlap ME; Corbalán R; Armstrong PW; Starling RC; O'Connor CM; Califf RM; Fonarow GC;
Circ Cardiovasc Qual Outcomes; 2013 Sep; 6(5):534-42. PubMed ID: 23899930
[TBL] [Abstract][Full Text] [Related]
25. Nesiritide in patients hospitalized for acute heart failure: does timing matter? Implication for future acute heart failure trials.
Wong YW; Mentz RJ; Felker GM; Ezekowitz J; Pieper K; Heizer G; Hasselblad V; Metra M; O'Connor CM; Armstrong PW; Starling RC; Hernandez AF
Eur J Heart Fail; 2016 Jun; 18(6):684-92. PubMed ID: 26817735
[TBL] [Abstract][Full Text] [Related]
26. The ASCEND-HF trial: an acute study of clinical effectiveness of nesiritide and decompensated heart failure.
Dandamudi S; Chen HH
Expert Rev Cardiovasc Ther; 2012 May; 10(5):557-63. PubMed ID: 22651831
[TBL] [Abstract][Full Text] [Related]
27. Effect of nesiritide in patients with acute decompensated heart failure.
O'Connor CM; Starling RC; Hernandez AF; Armstrong PW; Dickstein K; Hasselblad V; Heizer GM; Komajda M; Massie BM; McMurray JJ; Nieminen MS; Reist CJ; Rouleau JL; Swedberg K; Adams KF; Anker SD; Atar D; Battler A; Botero R; Bohidar NR; Butler J; Clausell N; Corbalán R; Costanzo MR; Dahlstrom U; Deckelbaum LI; Diaz R; Dunlap ME; Ezekowitz JA; Feldman D; Felker GM; Fonarow GC; Gennevois D; Gottlieb SS; Hill JA; Hollander JE; Howlett JG; Hudson MP; Kociol RD; Krum H; Laucevicius A; Levy WC; Méndez GF; Metra M; Mittal S; Oh BH; Pereira NL; Ponikowski P; Tang WH; Tanomsup S; Teerlink JR; Triposkiadis F; Troughton RW; Voors AA; Whellan DJ; Zannad F; Califf RM
N Engl J Med; 2011 Jul; 365(1):32-43. PubMed ID: 21732835
[TBL] [Abstract][Full Text] [Related]
28. Predictors of mortality after discharge in patients hospitalized with heart failure: an analysis from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF).
O'Connor CM; Abraham WT; Albert NM; Clare R; Gattis Stough W; Gheorghiade M; Greenberg BH; Yancy CW; Young JB; Fonarow GC
Am Heart J; 2008 Oct; 156(4):662-73. PubMed ID: 18926148
[TBL] [Abstract][Full Text] [Related]
29. Admission B-type natriuretic peptide levels and in-hospital mortality in acute decompensated heart failure.
Fonarow GC; Peacock WF; Phillips CO; Givertz MM; Lopatin M;
J Am Coll Cardiol; 2007 May; 49(19):1943-50. PubMed ID: 17498579
[TBL] [Abstract][Full Text] [Related]
30. Timing of immunoreactive B-type natriuretic peptide levels and treatment delay in acute decompensated heart failure: an ADHERE (Acute Decompensated Heart Failure National Registry) analysis.
Maisel AS; Peacock WF; McMullin N; Jessie R; Fonarow GC; Wynne J; Mills RM
J Am Coll Cardiol; 2008 Aug; 52(7):534-40. PubMed ID: 18687247
[TBL] [Abstract][Full Text] [Related]
31. Predictors of mortality in 6975 patients with chronic heart failure in the Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico-Heart Failure trial: proposal for a nomogram.
Barlera S; Tavazzi L; Franzosi MG; Marchioli R; Raimondi E; Masson S; Urso R; Lucci D; Nicolosi GL; Maggioni AP; Tognoni G;
Circ Heart Fail; 2013 Jan; 6(1):31-9. PubMed ID: 23152490
[TBL] [Abstract][Full Text] [Related]
32. Impact of early initiation of intravenous therapy for acute decompensated heart failure on outcomes in ADHERE.
Peacock WF; Fonarow GC; Emerman CL; Mills RM; Wynne J; ;
Cardiology; 2007; 107(1):44-51. PubMed ID: 16741357
[TBL] [Abstract][Full Text] [Related]
33. Acute systolic heart failure with normal admission BNP: clinical features and outcomes.
Omar HR; Guglin M
Int J Cardiol; 2017 Apr; 232():324-329. PubMed ID: 28094130
[TBL] [Abstract][Full Text] [Related]
34. A Canadian context for the Acute Study of Clinical Effectiveness of Nesiritide and Decompensated Heart Failure (ASCEND-HF) trial.
Armstrong PW; Rouleau JL
Can J Cardiol; 2008 Jul; 24 Suppl B(Suppl B):30B-2B. PubMed ID: 18629387
[TBL] [Abstract][Full Text] [Related]
35. Aetiology, timing and clinical predictors of early vs. late readmission following index hospitalization for acute heart failure: insights from ASCEND-HF.
Fudim M; O'Connor CM; Dunning A; Ambrosy AP; Armstrong PW; Coles A; Ezekowitz JA; Greene SJ; Metra M; Starling RC; Voors AA; Hernandez AF; Michael Felker G; Mentz RJ
Eur J Heart Fail; 2018 Feb; 20(2):304-314. PubMed ID: 29082629
[TBL] [Abstract][Full Text] [Related]
36. A validated risk score for in-hospital mortality in patients with heart failure from the American Heart Association get with the guidelines program.
Peterson PN; Rumsfeld JS; Liang L; Albert NM; Hernandez AF; Peterson ED; Fonarow GC; Masoudi FA;
Circ Cardiovasc Qual Outcomes; 2010 Jan; 3(1):25-32. PubMed ID: 20123668
[TBL] [Abstract][Full Text] [Related]
37. Prognostic Value of Baseline and Changes in Circulating Soluble ST2 Levels and the Effects of Nesiritide in Acute Decompensated Heart Failure.
Tang WH; Wu Y; Grodin JL; Hsu AP; Hernandez AF; Butler J; Metra M; Voors AA; Felker GM; Troughton RW; Mills RM; McMurray JJ; Armstrong PW; O'Connor CM; Starling RC
JACC Heart Fail; 2016 Jan; 4(1):68-77. PubMed ID: 26656144
[TBL] [Abstract][Full Text] [Related]
38. Usefulness of acute delirium as a predictor of adverse outcomes in patients >65 years of age with acute decompensated heart failure.
Uthamalingam S; Gurm GS; Daley M; Flynn J; Capodilupo R
Am J Cardiol; 2011 Aug; 108(3):402-8. PubMed ID: 21757045
[TBL] [Abstract][Full Text] [Related]
39. Prognostic Implications of Changes in Amino-Terminal Pro-B-Type Natriuretic Peptide in Acute Decompensated Heart Failure: Insights From ASCEND-HF.
Grodin JL; Liebo MJ; Butler J; Metra M; Felker GM; Hernandez AF; Voors AA; McMurray JJ; Armstrong PW; O'Connor C; Starling RC; Troughton RW; Tang WHW
J Card Fail; 2019 Sep; 25(9):703-711. PubMed ID: 30953792
[TBL] [Abstract][Full Text] [Related]
40. The PROTECT in-hospital risk model: 7-day outcome in patients hospitalized with acute heart failure and renal dysfunction.
O'Connor CM; Mentz RJ; Cotter G; Metra M; Cleland JG; Davison BA; Givertz MM; Mansoor GA; Ponikowski P; Teerlink JR; Voors AA; Fiuzat M; Wojdyla D; Chiswell K; Massie BM
Eur J Heart Fail; 2012 Jun; 14(6):605-12. PubMed ID: 22535795
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
